💡 Did you know?
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
History
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
Mangalam Drugs and Organics Limited is an India-based manufacturer of active pharmaceutical ingredients (APIs) and intermediates. Under the Company's Fight Malaria Program, it supplies anti-malaria APIs worldwide. Its products include API, intermediates and specialty…
Weekly engine runs — movement reflects the numbers, not analyst opinion.
A weak business.
Mangalam Drug Chem is scored on the pharma / healthcare framework. It keeps a thin -19.1% of every rupee of sales as net profit. Free cash flow is worth about -16.3% of its market value.
Net worth has actually shrunk (-13%/yr) — value is not being built. Return on equity is a weak -43.3%.
It trades at -1× earnings. The books come through clean — a forensic grade of A, and Altman puts distress risk in the safe zone.
A plain-English restatement of the figures on this page — rules-based, for education and research context, not investment advice or a recommendation.
| Ratio | Company | Sector | Read |
|---|---|---|---|
| P/E | -1.22 | — | — |
| P/B | 0.57 | — | — |
| EV/EBITDA | — | 19.15 | — |
| ROE | -43.33 | 0.68 | worse |
| ROCE | -13.36 | 6.87 | worse |
| ROA | -12.78 | 1.26 | worse |
| Quick Ratio | 0.27 | — | — |
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| Sun Pharmaceutical Industries | 40.6 | 5.0 | 13.8% |
| Divis Laboratories | 93.5 | 16.3 | 15.3% |
| Torrent Pharmaceuticals | 85.9 | 9.8 | 11.4% |
Revenue declined 27% in the latest year — a break from prior trajectory. Negative CAGR — the top line has shrunk over this window. Growth is decelerating — latest year grew slower than the year before.
2 of the 3 years shown had a loss — profitability is inconsistent. The latest year saw a -761% swing — check if it's a one-off or structural.
Operating margin has compressed from -3% to -21% — costs or competition are eating into profitability.
Negative ROE — the business is destroying shareholder value. Capital efficiency declining — ROE down 36pp.
EPS dropped in the latest year despite possible profit changes — dilution or a profit dip could be at play.
Operating cash flow has been positive every year — the business generates real cash, not just accounting profit. Investing outflows exceed operating cash — the company relies on external funding to finance expansion. Raising capital despite positive cash flow — could signal expansion plans or opportunistic fundraising.
When operating cash keeps pace with reported profit, earnings are cash-backed; a persistent shortfall is a quality flag.
Revenue fell 15% QoQ — could be seasonality or a genuine slowdown. Run-rate stepping up — recent quarters average 15% above earlier ones.
4 of 4 quarters loss-making — quarterly profitability is uneven. Profit jumped 43% QoQ — check if this is operating leverage or a one-off item.
P/E band unavailable — needs 5y of consistent EPS + price history.
Promoters at 35.6% — dispersed ownership; institutional flows drive the stock.
Produced by a rules-based engine over licensed exchange fundamentals — every sentence above is derived from the numbers shown, no analyst or AI opinion involved. Education and research context, not investment advice. We are not SEBI-registered as an Investment Adviser or Research Analyst.